SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO.,LTD. Shanghai Kindly Enterprise Development Group Co.,LTD. Share Price
Equities
603987
CNE100003076
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.58 CNY | +1.20% |
|
+7.67% | -20.55% |
| Sales 2024 * | 3.18B 439M 36.58B | Sales 2025 * | 3.76B 518M 43.23B | Capitalization | 3.34B 461M 38.47B |
|---|---|---|---|---|---|
| Net income 2024 * | 360M 49.68M 4.14B | Net income 2025 * | 441M 60.86M 5.07B | EV / Sales 2024 * | 1.05 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.89 x |
| P/E ratio 2024 * |
9.24
x | P/E ratio 2025 * |
7.58
x | Employees | 4,227 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.3% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.20% | ||
| 1 week | +7.67% | ||
| Current month | +2.16% | ||
| 1 month | -0.26% | ||
| 3 months | -9.11% | ||
| 6 months | -20.13% | ||
| Current year | -20.55% |
1 week
7.10
7.64
1 month
6.747.95
Current year
6.039.65
1 year
6.0314.70
3 years
6.0331.93
5 years
6.0331.93
10 years
5.0531.93
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Xin Zhang
CEO | Chief Executive Officer | 50 | 01/07/01 |
Xiao Yu Shen
DFI | Director of Finance/CFO | 40 | 01/05/01 |
| 66 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Feng Yang
BRD | Director/Board Member | 52 | 17/23/17 |
Jun Shao
BRD | Director/Board Member | 60 | 06/20/06 |
Xian Miao Zhang
CHM | Chairman | 66 | 01/11/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 7.58 | +1.20% | 4,807,320 |
| 25/24/25 | 7.49 | +1.49% | 3,416,300 |
| 24/24/24 | 7.38 | +1.10% | 2,786,703 |
| 23/24/23 | 7.3 | +0.14% | 4,372,091 |
| 22/24/22 | 7.29 | +3.55% | 7,096,765 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Shanghai Kindly Enterprise Development Group Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of medical puncture devices. The Companyâs products include syringes, infusion sets, transfusion sets, medical tubes, medical package materials, intervention accessories, medical catheters, as well as medical bags, among others. The Company distributes its products within domestic market and to overseas markets.
Calendar
27/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.58
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.55% | 461M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +4.01% | 1.13B |
- Stock Market
- Equities
- 603987 Stock
